CC-90001, a c-Jun N-terminal kinase (JNK) inhibitor, in patients with pulmonary fibrosis: design of a phase 2, randomised, placebo-controlled trial

• Paul W Noble,
• Luca Richeldi,
• David A Lynch,
• Steven Greenberg,
• THEODORE F REISS,
• Zoran Popmihajlov,
• Donna J Sutherland,
• Gerald S Horan,
• Atalanta Ghosh

Affiliations

Paul W Noble

8 Department of Medicine, Cedars Sinai Medical Center, Los Angeles, California, USA

Luca Richeldi

Division of Respiratory Medicine, A Gemelli University Hospital, Catholic University of the Sacred Heart Faculty of Medicine and Surgery, Rome, Italy

David A Lynch

3 Department of Radiology, National Jewish Health, Denver, Colorado, United States

Steven Greenberg

Bristol Myers Squibb, Princeton, New Jersey, USA

THEODORE F REISS

senior director

Zoran Popmihajlov

Bristol Myers Squibb, Princeton, New Jersey, USA

Donna J Sutherland

Bristol Myers Squibb, Princeton, New Jersey, USA

Gerald S Horan

Bristol Myers Squibb, Princeton, New Jersey, USA

Atalanta Ghosh

Bristol Myers Squibb, Princeton, New Jersey, USA